Antisense inhibition of focal adhesion kinase expression
First Claim
Patent Images
1. An antisense compound 8 to 30 nucleobases in length targeted to nucleobases 1-120 of the 5'"'"'-untranslated region, nucleobases 150-230 of the 5'"'"'-untranslated region, translational termination region or nucleobases 3424-3679 of the 3'"'"'-untranslated region of a nucleic acid molecule encoding human focal adhesion kinase (SEO ID NO:
- 1), wherein said antisense compound inhibits the expression of said focal adhesion kinase.
2 Assignments
0 Petitions
Accused Products
Abstract
Compounds, compositions and methods are provided for inhibiting FAK mediated signaling. The compositions comprise antisense compounds targeted to nucleic acids encoding FAK. Methods of using these antisense compounds for inhibition of FAK expression and for treatment of diseases, particularly cancers, associated with overexpression or constitutive activation of FAK are provided.
51 Citations
29 Claims
-
1. An antisense compound 8 to 30 nucleobases in length targeted to nucleobases 1-120 of the 5'"'"'-untranslated region, nucleobases 150-230 of the 5'"'"'-untranslated region, translational termination region or nucleobases 3424-3679 of the 3'"'"'-untranslated region of a nucleic acid molecule encoding human focal adhesion kinase (SEO ID NO:
- 1), wherein said antisense compound inhibits the expression of said focal adhesion kinase.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
15. An antisense compound up to 30 nucleobases in length targeted to the coding region of a nucleic acid molecule encoding human focal adhesion kinase, wherein said antisense compound inhibits the expression of said focal adhesion kinase and has a sequence comprising at least an 8 nucleobasic portion of SEQ ID NO:
- 11, 12, 14, 15, 30, 31 or 33.
- View Dependent Claims (16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)
-
29. An in vitro method of inhibiting migration of cells associated with expression of focal adhesion kinase comprising administering to said cells a therapeutically or prophylactically effective amount of an antisense compound 8 to 30 nucleobases in length targeted to a nucleic acid molecule encoding human focal adhesion kinase comprising SEQ ID NO:
- 18 wherein said antisense compound inhibits the expression of human focal adhesion kinase.
Specification